Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.

V P Y Tan Sze Hang Kevin LiuF Y F LamI F N HungM F YuenW K Leung

Published in: Alimentary pharmacology & therapeutics (2017)

Treatment with 2 weeks of rifaximin led to adequate relief of global dyspeptic symptoms, belching and post-prandial fullness/bloating in subjects with functional dyspepsia. The difference was more marked in females. (clinicaltrials.org NCT01643083).

Keyphrases

clinical trial
double blind
irritable bowel syndrome
helicobacter pylori infection
physical activity
replacement therapy
gastroesophageal reflux disease